NCT07026279
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07026279
Title A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Amplia Therapeutics Limited
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
UC Irvine Chao Family Cancer Centre NOT_YET_RECRUITING Orange California 92868-3217 United States Details
University of Florida Shands NOT_YET_RECRUITING Gainesville Florida 32608 United States Details
Icahn School of Medicine at Mount Sinai NOT_YET_RECRUITING New York New York 10029-5674 United States Details
Cleveland Clinic RECRUITING Cleveland Ohio 44106 United States Details
Vanderbilt University Medical Centre NOT_YET_RECRUITING Nashville Tennessee 37232 United States Details
GenesisCare RECRUITING St Leonards New South Wales 2065 Australia Details
Epworth Healthcare RECRUITING Richmond Victoria 3121 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field